Celularity Inc. stock is down -0.43% since 30 days ago. The next earnings date is Aug 22, 2023. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 60% of the previous 4 December’s closed higher than November.
Celularity Inc. develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company was incorporated in 2016 and is headquartered in Florham Park, New Jersey.